Speech-Language Pathologists in Melrose, FL Accepting Medicare
5 Speech-Language Pathologists found. Showing 1 - 5
 Erika Kicklighter, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25727 Ne State Road 26, Melrose, FL 32666 Phone: 352-475-3113 Fax: 352-475-5796 |
Doreen Blischak, PHD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 State Road 26, Melrose, FL 32666 Phone: 352-475-5726 |
Elisa Neale-tobener, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 861 Hwy 21, Melrose, FL 32666 Phone: 352-475-5726 Fax: 352-475-5726 |
 Neale & Associates, Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6484 Neale Rd, Melrose, FL 32666 Phone: 352-475-5726 Fax: 352-475-5726 |
Valerie Paige Williams, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 25727 Ne State Road 26, Melrose, FL 32666 Phone: 352-475-3113 Fax: 352-475-5796 |
News Archive
Depression increases ecstasy use in children
Children with symptoms of anxiety and depression may have an increased tendency to use ecstasy in adolescence or young adulthood, finds a study published online by the British Medical Journal.
ECDC sketches actions to reduce public health risks of mcr-1 gene spread
The recently recognised global distribution of the mcr-1 gene poses a substantial public health risk to the EU/EEA. The gene is widespread in several continents and has been detected in bacteria isolated from multiple different sources such as food-producing animals, food, the environment and humans.
Inovio signs agreement with OncoSec to sell non-DNA cancer vaccine technology
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has signed an agreement with OncoSec Medical Inc. providing for the sale to OncoSec of certain non-DNA vaccine technology and intellectual property relating to electroporation technology useful for electrochemical and cytokine based immune therapies for treating solid tumors.
Scientists develop microfabricated device to measure cellular forces during tissue development
A University of Pennsylvania-led collaboration of bioengineers studying the physical forces generated by individual cells has created a tiny micron-sized device that allows researchers to measure and manipulate cellular forces as assemblies of living cells reorganize themselves into tissues.
Trial results show routine oral cholera vaccination programme protects people living in endemic regions
An oral cholera vaccine given as part of routine health services is safe and protects against severe cholera in children and adults in urban Bangladesh where the disease is endemic, according to the first real-life trial of this vaccine published in The Lancet.
› Verified 3 days ago